It is not FDA-approved as a drug product
GSH has a molecular weight of 307.32 g/mol, a CAS number of 70-18-8, and a chemical formula of C10H17N3O6S
By reducing caloric intake through appetite suppression, improving insulin sensitivity, and directly stimulating hepatic lipid clearance, retatrutide may address multiple drivers of metabolic dysfunction-associated steatotic liver disease (MASLD) terminology increasingly used in UK and European clinical practice, though many NHS and NICE materials continue to use the older designation of non-alcoholic fatty liver disease (NAFLD)
Intensely hydrating and anti-inflammatory, this treatment promotes healing, and brightens the skin
Related: Can You Ask If Someone's Taking a GLP-1
Sak D, Erdenen F, Mderrisoglu C, et al